Skip to content

Twitter page opens in new window Linkedin page opens in new window Instagram page opens in new window

info@pharmaust.com+61 8 9202 6814

PharmAust (PAA)

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

December 1, Top 20 Shareholders

211201_Top_20_Holders_Report

Categories: News and Announcements 2021, Top 20 ShareholdersBy Richard Mollard December 1, 2021

Related posts

Jan 1, Top 20 Shareholders
January 1, 2022

December 1, Demonstration Batch Small MPL Tablets Completed
December 1, 2021

November 17, FightMND and COVID-19 Trials on Track
November 17, 2021

November 15, New Zealand Joins Phase 2B Pet Dog Trial
November 15, 2021

November 1, Top 20 Shareholders
November 1, 2021

October 21, AGM Presentation
October 21, 2021

Recent Articles

Jan 1, Top 20 Shareholders
January 1, 2022
December 1, Demonstration Batch Small MPL Tablets Completed
December 1, 2021
December 1, Top 20 Shareholders
December 1, 2021
November 17, FightMND and COVID-19 Trials on Track
November 17, 2021

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

TWITTER

PharmAustFollow

PharmAust is a clinical-stage biotech company developing drug discovery IP to treat cancer, viral and neurological diseases. ASX: $PAA FSE: $ECQ

PharmAust @PharmAust·

With four clinical trials kicking off, PharmAust is set for a busy 2022

https://stockhead.com.au/health/with-four-clinical-trials-kicking-off-pharmaust-is-set-for-a-busy-2022/

Reply on Twitter 1470975301907669000 Retweet on Twitter 14709753019076690004 Like on Twitter 147097530190766900013 Twitter 1470975301907669000

Copyright © 2020 Pharmaust. All rights reserved.

Website Design & Digital Marketing Perth by Total Click Solutions